Overview
Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria.
Indication
用于伴有或不伴有过敏性结膜炎的过敏性鼻炎（季节性和常年性）。慢性特发性荨麻疹的对症治疗。
Associated Conditions
- Allergic Rhinitis (AR)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/08/11 | Not Applicable | Recruiting | Md. Hazrat Ali | ||
2023/04/18 | Phase 3 | Recruiting | Guy Boeckxstaens | ||
2013/09/12 | Phase 4 | Completed | Grupo de Alergología Clínica y Experimental | ||
2013/07/25 | Phase 4 | Completed | |||
2010/06/16 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| KESTINE TABLET 10 mg | SIN09435P | TABLET, FILM COATED | 10.00mg | 7/31/1997 | |
| KESTINE FILM-COATED TABLET 20MG | SIN15644P | TABLET, FILM COATED | 20.0mg | 3/12/2019 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| EBASTINA NORMON 10 MG COMPRIMIDOS BUCODISPERSABLES EFG | Laboratorios Normon S.A. | 76306 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA ARISTO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Aristo Pharma Iberia S.L. | 68281 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
| EBASTINA SANDOZ 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Sandoz Farmaceutica S.A. | 67607 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA FORTE FLAS STADA 20 MG COMPRIMIDOS BUCODISPERSABLES EFG | Laboratorio Stada S.L. | 80257 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA ARISTO 10 MG COMPRIMIDO BUCODISPERSABLES EFG | 78157 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| EBASTINA SANDOZ 20 MG COMPRIMIDOS BUCODISPERSABLES EFG | Sandoz Farmaceutica S.A. | 78491 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA FLAS STADA 10 MG COMPRIMIDOS BUCODISPERSABLES EFG | Laboratorio Stada S.L. | 80256 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA NORMON 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Laboratorios Normon S.A. | 68485 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Medicamento Sujeto A Prescripción Médica | Commercialized |
| EBASTINA VIATRIS 20 MG COMPRIMIDOS BUCODISPERSABLES EFG | 78504 | COMPRIMIDO BUCODISPERSABLE | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| EBASTINA ALPROFARMA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Laboratorios Almirall S.L. | 68652 | COMPRIMIDO RECUBIERTO CON PELÍCULA | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.